ID

26883

Descripción

Study ID: 101468/199 Clinical Study ID: 101468/199 Study Title: An open label study conducted in healthy volunteers to characterize the pharmacokinetics of a new unmarketed formulation of ropinirole Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome Documentation part (Visit Description): Non-Serious Adverse Event

Palabras clave

Versiones (1)
  1. 27/10/17 27/10/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

27 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Pharmacokinetics of a new unmarketed formulation of ropinirole Non-Serious Adverse Event 101468/199

Inglés

Non-Serious Adverse Event

1 formularios  
Non-Serious Adverse Event
Descripción

Non-Serious Adverse Event

Alias
UMLS CUI-1
C1518404
UMLS CUI-2
C0244821
Did the subject experience any non-serious adverse events during the study?
Descripción

If Yes, record details below. Note: If this is a Serious Adverse Event (SAE), do not complete this form, go to the SAE section and complete the SAE form.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1518404
Event
Descripción

Diagnosis Only (if known). Otherwise Sign/Symptom

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0011900
Start date Non-Serious Adverse Event
Descripción

Start date Non-Serious Adverse Event

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0808070
Start Time Non-Serious Adverse Event
Descripción

Start Time Non-Serious Adverse Event

Tipo de datos

time

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C2697889
Outcome Non-Serious Adverse Event
Descripción

Outcome Non-Serious Adverse Event

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1705586
UMLS CUI [1,2]
C1518404
End Date Non-Serious Adverse Event
Descripción

End Date Non-Serious Adverse Event

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0806020
End Time Non-Serious Adverse Event
Descripción

End Time Non-Serious Adverse Event

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2826658
UMLS CUI [1,2]
C1518404
Frequency of Non-Serious Adverse Event
Descripción

Frequency of Non-Serious Adverse Event

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0439603
Maximum Intensity
Descripción

Non-Serious Adverse Event

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1710066
UMLS CUI [1,2]
C1518404
Action Taken with Investigational Product(s) as a Result of the Non-Serious AE
Descripción

Action Taken

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2826626
UMLS CUI [1,2]
C1518404
Did the subject withdraw from study as a result of this AE?
Descripción

withdrawal

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1518404
Is there a reasonable possibility that the AE may have been caused by the investigational product?
Descripción

AE caused by the investigational product

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0085978
UMLS CUI [1,2]
C1518404
Volver a la parte superior de la página

Similar models

Non-Serious Adverse Event

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Non-Serious Adverse Event
C1518404 (UMLS CUI-1)
C0244821 (UMLS CUI-2)
non-serious adverse events
Item
Did the subject experience any non-serious adverse events during the study?
boolean
C1518404 (UMLS CUI [1])
Event
Item
Event
text
C1518404 (UMLS CUI [1,1])
C0011900 (UMLS CUI [1,2])
Start date Non-Serious Adverse Event
Item
Start date Non-Serious Adverse Event
date
C1518404 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Start Time Non-Serious Adverse Event
Item
Start Time Non-Serious Adverse Event
time
C1518404 (UMLS CUI [1,1])
C2697889 (UMLS CUI [1,2])
Item
Outcome Non-Serious Adverse Event
integer
C1705586 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Outcome
Code List
Outcome Non-Serious Adverse Event
CL Item
Recovered/Resolved (1)
C2826210 (UMLS CUI-1)
(Comment:en)
CL Item
Recovering/Resolving (2)
C0521108 (UMLS CUI-1)
(Comment:en)
CL Item
Not recovered/Not resolved (3)
C1709277 (UMLS CUI-1)
(Comment:en)
CL Item
Recovered/Resolved withsequelae (4)
C1709862 (UMLS CUI-1)
(Comment:en)
End Date Non-Serious Adverse Event
Item
End Date Non-Serious Adverse Event
date
C1518404 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
End Time Non-Serious Adverse Event
Item
End Time Non-Serious Adverse Event
text
C2826658 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Item
Frequency of Non-Serious Adverse Event
integer
C1518404 (UMLS CUI [1,1])
C0439603 (UMLS CUI [1,2])
Frequency of Non-Serious Adverse Event
Code List
Frequency of Non-Serious Adverse Event
CL Item
Single episode (1)
CL Item
Intermittent (2)
Item
Maximum Intensity
integer
C1710066 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Maximum Intensity
Code List
Maximum Intensity
CL Item
Mild (1)
C2945599 (UMLS CUI-1)
(Comment:en)
CL Item
Moderate (2)
C0205081 (UMLS CUI-1)
(Comment:en)
CL Item
Severe (3)
C0205082 (UMLS CUI-1)
(Comment:en)
CL Item
Not applicable (4)
Item
Action Taken with Investigational Product(s) as a Result of the Non-Serious AE
integer
C2826626 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Action Taken
Code List
Action Taken with Investigational Product(s) as a Result of the Non-Serious AE
CL Item
Investigational product(s) withdrawn (1)
C1875319 (UMLS CUI-1)
(Comment:en)
CL Item
Dose reduced (2)
C1707814 (UMLS CUI-1)
(Comment:en)
CL Item
Dose increased (3)
C1707810 (UMLS CUI-1)
(Comment:en)
CL Item
Dose not changed (4)
C0178602 (UMLS CUI-1)
C0443172 (UMLS CUI-2)
(Comment:en)
CL Item
Dose interrupted (5)
C1512900 (UMLS CUI-1)
C0178602 (UMLS CUI-2)
(Comment:en)
CL Item
Not applicable (6)
withdrawal
Item
Did the subject withdraw from study as a result of this AE?
boolean
C2349954 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
AE caused by the investigational product
Item
Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
C0085978 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial